Epigenomics
IPOEpigenomics was founded in 1998, is headquartered in Berlin, Germany, and has $22.5M in recorded funding across 1 round.
- Headquarters
- Berlin
- Founded
- 1998
- Business Model
- B2B
- Website
- epigenomics.com
- Total Funding
- $22.5M
- Last Round
- $22.5M Series CApr 2008
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Epigenomics AG is a molecular diagnostics company developing blood-based DNA methylation tests for early cancer detection.
Summary
Epigenomics is a Biotech company based in Berlin, Germany, founded in 1998. It has raised $22.5M in total across 1 round, most recently a $22.5M Series C round in Apr 2008. Investors include Omega Funds.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
2017 (est.)
Sign up to see all 3 events
Funding: Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/epigenomics"><img src="https://indexed.vc/api/badge/company/epigenomics" alt="Epigenomics on Indexed.vc" width="260" height="76" /></a>